PROFILE |
 |
Donlar BioSyntrex Corporation is the result of Donlar's acquisition of Biomune. The company commercializes a proprietary, biodegradable polymer that is hypoallergenic and nontoxic and is meant to replace traditional polyacrylates (polymers). Donlar is targeting the agricultural, pharmaceutical, and specialty chemical markets. Its so-called biopolymers, or thermal polyaspartates, can be used in crop nutrient management, oil production, detergents, coatings, personal care products, and water treatment. Donlar partners with companies such as BP Amoco to help develop and distribute its biopolymers, which it produces in Peru, Illinois.
COMPETITION |
 |
Engelhard Corporation (EC)
Rohm and Haas Company (ROH)
Uniroyal Chemical Corporation (dossier)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
1997 Sales (mil.): 5.00
1-Yr. Sales Growth: 133.4%
Employees: 56
Revenue per employee: $89,285.71
KEY PEOPLE |
 |
Larry P. Koskan
CEO
Joel H. Lurquin
CFO
CONTACT INFO |
 |
6502 S. Archer Rd.
Bedford Park, IL 60501
US
Phone: 708-563-9200
Fax: 708-563-9220
Online: Web Site
|